Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.

Pharmacogenetics and genomics - 1 Oct 2010

Hu Miao, Lui Sandra S H, Mak Valiant W L, Chu Tanya T W, Lee Vivian W Y, Poon Emily W M, Tsui Teresa K C, Ko Gary T C, Baum Larry, Tam Lai-Shan, Li Edmund K, Tomlinson Brian

Abstract excerpt

Lipid changes with statin treatments vary greatly between individuals for reasons which are largely unknown. This study was performed to examine the genetic determinants of lipid responses to rosuvastatin in Chinese patients. A total of 125 polymorphisms in 61 candidate genes from 386 Chinese patients were analyzed for association with the lipid responses to rosuvastatin 10 mg daily. The polymorphisms most highly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipid Metabolism

Share to Patient Compliance

Share to Pharmacogenetics

Share to Pyrimidines

Share to Rosuvastatin Calcium

Share to Sulfonamides

Source

Identifiers

PMID: 20679960
DOI: 10.1097/FPC.0b013e32833de489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.PMID 20679960Read ↗

Pharmacogenomic analysis of low-density lipoprotein receptor 3' untranslated region genetic variants influencing rosuvastatin efficacy in Chinese dyslipidemia patients.Semantic proximity Read ↗

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.Semantic proximity Read ↗

Genetic determinants of response to statins.Semantic proximity Read ↗

Genetic contribution to lipid target achievement with statin therapy: a prospective study.Semantic proximity Read ↗

Seventeen years of statin pharmacogenetics: a systematic review.Semantic proximity Read ↗

Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia.Semantic proximity Read ↗

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.Semantic proximity Read ↗

Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population.Semantic proximity Read ↗

Effect of ABCG2 c.421 C> A (rs2231142) single nucleotide polymorphisms on the lipid-modulating efficacy of rosuvastatin: a meta-analysis.Semantic proximity Read ↗

The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid-Lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low-Density Lipoprotein.Semantic proximity Read ↗

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.Semantic proximity Read ↗

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.